Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis - 12/10/21

Abstract |
Primary cutaneous T-cell lymphomas (CTCLs) are defined as lymphomas with a T-cell phenotype that present in the skin without evidence of systemic or extracutaneous disease at initial presentation. CTCLs other than mycosis fungoides and Sézary syndrome (SS) account for approximately one third of CTCLs and encompass a heterogenous group of non-Hodgkin lymphomas, ranging from indolent lymphoproliferative disorders to aggressive malignancies with a poor prognosis. The spectrum of CTCLs continues to broaden as new provisional entities are classified. Given the morphologic and histologic overlap among CTCLs and other diagnoses, a thorough clinical history, physical evaluation, and clinicopathologic correlation are essential in the work up and diagnosis of these rare entities. This article will summarize the epidemiologic, clinical, pathologic, and diagnostic features of CTCLs other than mycosis fungoides and SS.
Le texte complet de cet article est disponible en PDF.Key words : adult T-cell lymphoma, adult T-cell leukemia, angioimmunoblastic T-cell lymphoma, CD30+ lymphoproliferative disorders, cutaneous T-cell lymphoma, cytotoxic primary cutaneous anaplastic large cell lymphoma, extranodal NK/T-cell lymphoma, nasal type, lymphomatoid papulosis, mycosis fungoides, peripheral T-cell lymphoma, not otherwise specified, primary cutaneous acral CD8+ T-cell lymphoma, primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder, primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma, primary cutaneous gamma-delta T-cell lymphoma, Sézary syndrome, subcutaneous panniculitis-like T-cell lymphoma, T-cell lymphoma
Abbreviations used : AECTCL, AITL, ATLL, CAEBV, CTCL, EBV, ENKTL, EORTC, HPS, HTLV-1, HV, LPD, LyP, MF, pcALCL, PCGDTCL, PCSM-TCLPD, PTCL-NOS, SS, SPTCL, TCL, TCR
Plan
| Funding sources: None. |
|
| Date of release: November 2021. |
|
| Expiration date: November 2024. |
Vol 85 - N° 5
P. 1073-1090 - novembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
